0
Letters |

Radiation Exposure and Thyroid Disease in Hiroshima and Nagasaki Atomic Bomb SurvivorsRadiation Exposure and Thyroid Disease in Hiroshima and Nagasaki Atomic Bomb Survivors

JAMA. 2006;296(5):512-513. doi:10.1001/jama.296.5.512-a
Text Size: A A A
Published online

AUTHOR INFORMATION

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

RADIATION EXPOSURE AND THYROID DISEASE IN HIROSHIMA AND NAGASAKI ATOMIC BOMB SURVIVORS

To the Editor: Dr Imaizumi and colleagues1 reported a dose-response relationship between radiation exposure and thyroid disorders using data from a cohort of atomic bomb survivors from Hiroshima and Nagasaki. The strengths of this study include the large population and the accurately defined exposure estimates and end points.

More sophisticated methods to precisely define thyroid disorders might accurately detect radiation effects on the thyroid for diseases other than malignancies. While dose-response associations of radiation exposure with thyroid malignancies, benign nodules, and cysts were consistent over a number of analyses, Imaizumi et al found no significant relation between exposure to radiation and positive levels of antithyroid peroxidase antibody (TPOAb). In their study, a TPOAb cutoff of 10 IU/mL was chosen to define positivity. However, no justification for this choice was given.

Reference values provided by manufacturers might not be sufficiently specific to accurately define autoimmune thyroid disease, and definitions of positive TPOAb levels based on higher cutoffs might have been useful. For example, we found a statistically significant relationship between occupational exposure to ionizing radiation and autoimmune thyroid disease by using TPOAb cutoffs that were at least twice as high as the manufacturer's recommendation.2 While the inclusion of TPOAb in the definition of autoimmune thyroid disease was useful in the subpopulation of women, our data also have indicated that TPOAb levels were less suitable to describe the radiation-related risk of autoimmune thyroid disease among males compared with hypoechogenicity in thyroid ultrasound.2

Given the general variability of TPOAb methods and that diffuse reduction in thyroid echogenicity indicative of lymphocytic infiltration is often seen before TPOAb can be detected,3 it would be of interest if the authors could analyze their data using ultrasound markers of autoimmune thyroid disease as alternative dependent variables.

Financial Disclosures: None reported.

References
Imaizumi M, Usa T, Tominaga T.  et al.  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure.  JAMA. 2006;2951011-1022
PubMed
Völzke H, Werner A, Wallaschofski H.  et al.  Occupational exposure to radiation is associated with autoimmune thyroid disease.  J Clin Endocrinol Metab. 2005;904587-4592
PubMed
Pedersen OM, Aardal NP, Larssen TB, Varhaug JE, Myking O, Vik-Mo H. The value of ultrasonography in predicting autoimmune thyroid disease.  Thyroid. 2000;10251-259
PubMed

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Imaizumi M, Usa T, Tominaga T.  et al.  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure.  JAMA. 2006;2951011-1022
PubMed
Völzke H, Werner A, Wallaschofski H.  et al.  Occupational exposure to radiation is associated with autoimmune thyroid disease.  J Clin Endocrinol Metab. 2005;904587-4592
PubMed
Pedersen OM, Aardal NP, Larssen TB, Varhaug JE, Myking O, Vik-Mo H. The value of ultrasonography in predicting autoimmune thyroid disease.  Thyroid. 2000;10251-259
PubMed
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.